Rating History for Amylin Pharmaceuticals (AMLN) by Baird

More Stocks Rated by Baird | Latest Ratings for AMLN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/2/2012 N/A Maintain Neutral
(N/A)		 31.00
(28.00)		  
 		   Details